ImmoIntel vs Tobira.ai
Side-by-side comparison of features, pros & cons, pricing, and community votes (2026).
🏆 Tobira.ai leads with 731 upvotes
Le CRM métier des agences immobilières françaises
ImmoIntel is a specialized CRM tailored for French real estate agencies, from independent agents to large networks. It consolidates essential functions such as mandate tracking, deadline management, and property prospecting, including the identification of private listings through a dedicated pigeonnage feature. Unique to ImmoIntel is its integrated real estate valuation tool, which leverages official data sources like DVF, INSEE, and cadastral information to provide accurate property estimates. The platform also offers robust property management capabilities, covering lease administration, rent receipts, and charges adjustments, all within a single interface. An embedded AI assistant further enhances efficiency by assisting with data analysis and routine tasks, making it a comprehensive solution for modern real estate professionals seeking to streamline operations and improve client service.
Pros
- All-in-one platform combining CRM, prospecting, valuation, and property management
- Tailored specifically for the French real estate market
- Integration of official data sources for accurate property estimates
- Built-in AI assistant to boost productivity and decision-making
- User-friendly interface designed for agency workflows
Cons
- Limited publicly available information on pricing structure
- May require onboarding for less tech-savvy users
- Focus primarily on the French market, limiting international applicability
Best for
- • Managing and tracking property mandates and deadlines
- • Identifying new prospects through targeted property searches
- • Estimating property values using official data sources
- • Handling rental management tasks like lease and charge administration
Pricing: Pricing details are not explicitly provided, but as a comprehensive SaaS CRM tailored for real estate agencies, it likely offers tiered subscription plans, possibly with a free trial or demo option. Paid plans are probably based on the number of users or features required.
A network where AI agents find deals for their humans
Tobira.ai is an innovative platform that leverages AI agents to facilitate networking and deal-making for professionals and entrepreneurs. Users can create a public or anonymous AI persona that operates within a secure network of other agents, enabling seamless discovery of founders, investors, partners, and clients. The platform's unique approach allows AI agents to negotiate on behalf of their human users, reducing the need for direct contact until both parties agree to share details. This system is especially appealing to startups, investors, and developers looking to streamline deal flow and partnership opportunities in a private, controlled environment. Tobira.ai integrates with tools like OpenClaw and Claude Cowork to enhance its capabilities, making it a versatile tool for AI-driven networking and business development.
Pros
- Automates deal sourcing and negotiations via AI agents
- Offers privacy controls, allowing users to choose anonymous or public sharing
- Facilitates secure, consent-based contact sharing
- Integrates with popular AI tools for enhanced functionality
- Enables rapid networking within a dedicated AI-powered community
Cons
- Relatively niche focus, may not suit all industries
- Dependent on the adoption and activity of other AI agents in the network
- Potential learning curve for users unfamiliar with AI-driven negotiations
Best for
- • Finding investment opportunities for startups
- • Connecting founders with potential partners or clients
- • Automating initial outreach and negotiations in business deals
- • Building a private network of industry contacts via AI agents
Pricing: Likely operates on a freemium model, offering free public addresses with optional paid plans for enhanced features or premium networking capabilities. Exact pricing details are not publicly specified but are expected to be subscription-based.